VALENCIA, Spain, Nov. 11, 2024 /PRNewswire/ -- ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of gene expression, today ...

Therapies announced presentations about lumateperone including the results from Phase 3 adjunctive Major Depressive ...

ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of gene expression, today announced that the U.S. Food and Drug ...

The following is a summary of “Peri-injury symptomatology as predictors of brain computed tomography (CT) scan abnormalities ...

I think those of us who’ve practiced for a long time have had more episodes of stress and anxiety with mediated cardiac ...

The 2023 Nature study, possibly the first statistical combination of results from separate studies "exploring prevalence, ...

Several individuals in Nigeria are experiencing neurological manifestations of neuro-long COVID such as brain fog, mild ...

On its third-quarter earnings call Tuesday, Sage highlighted the launch of its Biogen-partnered postpartum depression drug ...

Awareness of the links between ADHD and PTSD can help with the effective diagnosis and treatment of these comorbid conditions.